Bill116th CongressFiled Jan 3, 2019Health
H.R. 107
To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jan 3, 2019)
This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020.
What just happenedJan 25, 2019
Referred to the Subcommittee on Health.
Who’s behind it
Rep. Burgess, Michael C. [R-TX-26](R-TX)Sponsor
1committees4actions1related bills3subjects
- Introduced in HouseJan 3, 2019
- Jan 25, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jan 3, 2019IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jan 3, 2019IntroReferralIntro-H
Introduced in House
- Jan 3, 2019IntroReferral1000
Introduced in House